Immunomedics (IMMU) Misses Q4 EPS by 6c

August 17, 2016 4:01 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Immunomedics (NASDAQ: IMMU) reported Q4 EPS of ($0.17), $0.06 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $900 thousand versus the consensus estimate of $1.2 million.

For earnings history and earnings-related data on Immunomedics (IMMU) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment